Introduction: Patients on hemodialysis (HD) or peritoneal dialysis (PD) were consistently reported to have a high prevalence of vitamin D deficiency. However, there are limited data among Asian population. Objective: To assess the prevalence of Serum 25(OH)-vitamin D deficiency in patients on maintenance HD and PD in Sarawak General Hospital. Methods: This cross sectional study was conducted from November 2015 to September 2016. Patients were classified as vitamin D deficient (<20 ng/ml), insufficient (21 and 29 ng/ml) or sufficient (>30 ng/ml). Results: Of the 170 patients, 101 were on HD and 69 were on CAPD. In HD patients, vitamin D deficiency was found in 7.9% of the patients (n ¼ 8), and insufficiency in 22.8% (n ¼ 23). In CAPD patients, vitamin D deficiency was found in 49.3% of the patients (n ¼ 34), and insufficiency in 30.4% (n ¼ 21).Among HD patients, those with serum 25(OH)D concentrations of <30 ng/ml were predominantly female (p¼ 0.000) and diabetic (p¼0.003). There were significant correlation between serum 25(OH)D and body mass index (p ¼ 0.026), waist circumference (p ¼ 0.031), dialysis vintage (p ¼ 0.005), and magnesium (p ¼ 0.001). There was no correlation with age, corrected calcium, albumin, phosphate, alkaline phosphatase, or intact parathyroid hormone level.Among PD patients, those with serum 25(OH)D concentrations of <30 ng/ml were predominantly female (p¼ 0.004), Malay race (p ¼0.000), urban locality (P ¼0.013) and diabetic (p¼0.000). There was no significant correlation with all the other demographic or laboratory parameters. Conclusions: Our study showed that vitamin D deficiency/insufficiency is highly prevalent among PD patients. However, the majority of our HD patients are not vitamin D deficient. Other risk factors identified include diabetes, female gender, and urban locality. Interestingly, the prevalence of vitamin D deficiency is very low among the Bidayuh patients. Further studies are needed to explore the reason for this and also the consequences of vitamin D deficiency and possible therapeutic interventions.
Among the group who had hypoperfusion, 94.4% were post cardiac surgery, of which 84.9% had cyanotic congenital heart disease. Treatment with peritoneal dialysis occurred in intensive care unit in 93.8% of the patients. It is associated with mechanical ventilation in 92.1%, use of two or more inotropes in 85.3% and two or more organ dysfunction in 71.2%. The indications for peritoneal dialysis were fluid overload(60.5%), uraemia and fluid overload(26.6%), uraemia(11.9%) and others(1.7%). Technique failure occurred in 1.1% of the patients and they were switched to haemodialysis. Mortality in our PD cohort was 30.5%. Age, weight, gender and primary aetiology of AKI were not significant risk factors of death. At hospital discharge, mean serum creatinine was 47.6(CI 34.3-60.9)mcmol/ L and estimated glomerular filtration rate(eGFR) was 89.7(CI 78.5-100.9) mls/min/1.73m 2. 10% of the patients had eGFR less than 60mls/min/m 2. None of the survivors developed end stage renal failure at hospital discharge. Conclusions: PD offers good patient survival and renal outcome as evidenced in our cohort. Hence, PD is a viable first line renal replacement therapy in severe AKI for young children with low body weight even if they are critically ill.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.